Frontal assessment battery in a Persian population with Parkinson's disease
International Clinical Neuroscience Journal,
Vol. 1 No. 1 (2014),
11 Mordad 2014
,
Page 18-21
https://doi.org/10.22037/icnj.v1i1.6503
Abstract
Background: Several studies have indicated that executive dysfunction is the main neuropsychological feature of Parkinson’s disease (PD). The Frontal Assessment Battery (FAB) is a short tool for the assessment of executive functions. Purpose: The aim of this study was to determine the relationship between Persian version of FAB scores and age, education, Mini-Mental State Examination (MMSE), and severity of the disease in Iranian patients with PD. Methods: The study involved 60 healthy participants and 60 patients with idiopathic PD. Age, sex, disease duration, and Unified Parkinson’s Disease Rating Scale (UPDRS) scores were noted. FAB and MMSE were administered to all participants. Both groups were compared according to FAB scores, MMSE, age, and education. Results: FAB scores were significantly lower in patients with PD than in healthy controls (P<0.05). In patients with PD, FAB scores were correlated with MMSE (P<0.05) but not with UPDRS (P=0.93). Conclusion: FAB scores were significantly lower in Iranian patients with PD in comparison to controls and it can indicate that this battery has good discriminate validity and can be a useful tool to identify executive dysfunction in Iranian patients with Parkinson’s disease. Also it seems that FAB is not useful test to show disease severity in Iranian patients.
- executive functions
- Parkinson disease
- frontal assessment battery (FAB)
- UPDRS
How to Cite
References
Melo LMB, Barbosa ER, Caramelli P. Declínio cognitivo e demência associados à doença de Parkinson: características clínicas e tratamento. Rev Psiq Clín.
;34(4):176-183.
Tolosa E, Wenning G, Poewe W. The Diagnosis of
Parkinson’s disease. Lancet Neurol. 2006;5(1):75-86.
Padovani AC, Gilbert CN, Borroni B. Parkinson’s disease
and dementia. Neurol Sci. 2006; 27(1):S40-S43.
Galvin JE, Pollack J, Morris JC. Clinical phenotype of
Parkinson disease dementia. Neurology. 2006;67(9):1605-
Galvin JEG, Cognitive change in Parkinson Disease.
Alzheimer Dis Assoc Disord. 2006;20(4):302-10.
Shobhas SR, Hofmann LA, Shakil A. Parkinson’s disease:
diagnosis and treatment. Am Fam Phisician.
;74(12):2046-2053.
Bosboom JLW, Stoffers D, Wolters EC. Cognitive
dysfunction and dementia in Parkinson’s disease. J Neural
Transm. 2004; 111(10-11):1303-1315.
Janvin CC, Aarsland D, Larsen JP. Cognitive predictors of dementia in Parkinson’s disease: a community-based, 4- year longitudinal study. J Geriatr Psychiatry Neurol.
;18(13):149-154.
Poewe W. Non-motor symptoms of Parkinson’s disease. In: Jankovic J, Tolosa E, eds. Parkinson’s Disease and Movement Disorders. Philadelphia: Lippincott Williams & Wilkins; 2007:67–76.
Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB, a frontal assessment battery at bedside. Neurology.
;55(11):1621–1626.
Takagi R, Kajimoto Y, Kamiyoshi S, Miwa H, Kondo T. The frontal assessment battery at bedside (FAB) in patients with Parkinson’s disease. No To Shinkei. 2002;54(10):897–
Lees AJ, Smith E. Cognitive deficits in the early stages
of Parkinson’s disease. Brain. 1983;106 (Pt 2):257-70.
Taylor AE, Saint-Cyr JA, Lang AE. Frontal lobe dysfunction in Parkinson’s disease. The cortical focus of neostriatal outflow. Brain. 1986;109(Pt 5):845– 883.
Burgess P. Assessment of executive function. In: Halligan P, Kischka U, Marshall J, eds. Handbook of Clinical Neuropsychology. Oxford: Oxford University Press.
;302–321.
Guedj E, Allali G, Goetz C, Le Ber I, Volteau
M, Lacomblez L, et al. Frontal Assessment Battery is a marker of dorsolateral and medial frontal functions: aSPECT study in frontotemporal dementia. J Neurol Sci.
;273(1-2):84–87.
Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in
Parkinson’s disease: a clinicopathologic study. Neurology.
;42(6):1142–1146.
Fahn S, Elton RS, Jenner P, Marsden CD, Teychenne P, Calne DB. Members of the UPDRS Development Committee. Unified Parkinson’s disease rating scale. Recent Developments in Parkinson’s Disease. Florham Park NJ: Macmillan Publishers. 1987;153–163.
Folstein M, Folstein S, McHugh P. Mini-Mental State: A
practical method for grading the cognitive state of patients for the clinician. J Psych Res. 1975;12(3):189–198.
Kenangil G, Orken DN, Ur E, Forta H. Frontal Assessment Battery in Patients With Parkinson Disease in a Turkish Population. Cog Behav Neurol. 2010;23(1):26-28.
Lima CF, Meireles LP, Fonseca R, Luís Castro S, Garrett C. The frontal assessment battery (FAB) in Parkinson’s disease and correlations with formal measures of executive functioning. J Neurol. 2008;255(11):1756–1761.
Apollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, et al. The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol Sci. 2005;26(2):108–116.
Iavarone A, Ronga B, Pellegrino L, Lorè E, Vitaliano S, Galeone F, et al. The frontal assessment battery (FAB): Normative data from an Italian sample and performance of patients with Alzheimer’s disease and frontotemporal dementia. Func Neurol. 2004;19:191–195.
Beato R, Nitrini R, Formigoni A, Caramelli P. Brazilian
version of the Frontal Assessment Battery (FAB): Preliminary data on administration to healthy elderly. Dement Neuropsychol. 2007;1:59–65.
Dennis JA. A review of the cognitive and behavioral sequelae of Parkinson’s disease: relationship to frontostriatal circuitry. Cogn Behav Neurol.
;16(4):193–210.
Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, et al. Frontal assessment battery and brain perfusion image in Parkinson’s disease. J Geriatr Psychiatry Neurol.
;19(1):41–45.
- Abstract Viewed: 435 times
- PDF Downloaded: 208 times